Hierarchically electrospraying a PLGA@chitosan sphere-in-sphere composite microsphere for multi-drug-controlled release.

Sequential administration and controlled release of different drugs are of vital importance for regulating cellular behaviors and tissue regeneration, which usually demands appropriate carriers like microspheres (MS) to control drugs releases. Electrospray has been proven an effective technique to prepare MS with uniform particle size and high drug-loading rate. In this study, we applied electrospray to simply and hierarchically fabricate sphere-in-sphere composite microspheres, with smaller poly(lactic-co-glycolic acid) MS (∼8-10 µm in diameter) embedded in a larger chitosan MS (∼250-300 µm in diameter). The scanning electron microscopy images revealed highly uniform MS that can be accurately controlled by adjusting the nozzle diameter or voltage. Two kinds of model drugs, bovine serum albumin and chlorhexidine acetate, were encapsulated in the microspheres. The fluorescence-labeled rhodamine-fluoresceine isothiocyanate (Rho-FITC) and ultraviolet (UV) spectrophotometry results suggested that loaded drugs got excellent distribution in microspheres, as well as sustained, slow release in vitro. In addition, far-UV circular dichroism and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI-TOF-MS) results indicated original secondary structure and molecular weight of drugs after electrospraying. Generally speaking, our research proposed a modified hierarchically electrospraying technique to prepare sphere-in-sphere composite MS with two different drugs loaded, which could be applied in sequential, multi-modality therapy.

Corrigendum to: Hierarchically electrospraying a PLGA@chitosan sphere-in-sphere composite microsphere for multi-drug-controlled release.

[This corrects the article DOI: 10.1093/rb/rbaa009.][This corrects the article DOI: 10.1093/rb/rbaa009.].

Functional evaluation of transplanted kidneys in normal function and acute rejection using BOLD MR imaging.

In this study, we evaluated a large number of subjects using BOLD MRI to provide more information about oxygen metabolism in the normal function of transplanted kidneys and to distinguish acute graft rejection from normal function kidneys. This study included 122 subjects (20 volunteers, 72 patients with normal functioning transplants, and 21 patients with acute rejection), and 9 patients had normal function grafts received examination while grafts dysfunction occurred within 6 months during the follow-up. The R2 (1/s) values in the cortex and medulla as well as the R2 ratio of the medulla to cortex (R2 ratio of M/C) were recorded. The R2 values of the medulla were higher than those of the cortex in the normal function group and the volunteers which have a steep R2 ratio of M/C. All the R2 values in the acute rejection group were lower than those in the normal function grafts group (P<0.001). Moreover, in the 9 patients as normal function, the R2 values of the cortex and medulla were different from the normal function grafts, which was lower in 5 patients and was higher in the 4 remaining patients. Conversely, the R2 ratios of M/C of the 9 patients were similar to those in the normal function group. BOLD MRI shows that decreased R2 values of the cortex and medulla and R2 ratio of M/C suggest acute renal graft rejection; furthermore, a steep R2 ratio of M/C (>1.1) is an important reason for keeping clinical normal function.